Clinical Response to Adalimumab Therapy is Associated with Increased Fecal Short Chain Fatty Acids in Hidradenitis Suppurativa
Published: 3 November 2021| Version 1 | DOI: 10.17632/36bj7rmsnn.1
Contributor:
John FrewDescription
FASTQ Files for article "Clinical Response to Adalimumab Therapy is Associated with Increased Fecal Short Chain Fatty Acids in Hidradenitis Suppurativa"
Files
Categories
Microbiome, Short Chain Fatty Acid